References
- Aranda J V, Thomas R. Systematic review: intravenous Ibuprofen in preterm newborns. Semin Perinatol 2006; 30: 114–120
- Thomas R L, Parker G C, Van Overmeire B, Aranda J V. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005; 164: 135–140, Epub 2004 Dec 10
- Lago P, Bettiol T, Salvadori S, Pitassi I, Vianello A, Chiandetti L, Saia O S. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr 2002; 161: 202–207
- Van Overmeire B, Smets K, Lecoutere D, Van de Broek H, Weyler J, Degroote K, Langhendries J P. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med 2000; 343: 674–681
- Van Overmeire B, Brus F, van Acker KJ, van der Auwera JC, Schasfoort M, Elzenga N J, Okken A. Aspirin versus indomethacin treatment of patent ductus arteriosus in preterm infants with respiratory distress syndrome. Pediatr Res 1995; 38: 886–891
- Heymann M A, Rudolph A M, Silverman N H. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976; 295: 530–533
- Ito K, Niida Y, Sato J, Owada E, Ito K, Umetsu M. Pharmacokinetics of mefenamic acid in preterm infants with patent ductus arteriosus. Acta Paediatr Jpn 1994; 36: 387–391
- Sakhalkar V S, Merchant R H. Therapy of symptomatic patent ductus arteriosus in preterms using mefenemic acid and indomethacin. Indian Pediatr 1992; 29: 313–318
- Ng P C, So K W, Fok T F, Yam M C, Wong M Y, Wong W. Comparing sulindac with indomethacin for closure of ductus arteriosus in preterm infants. J Paediatr Child Health 1997; 33: 324–328
- Ng P C, So K W, Fok T F, To K F, Wong W, Liu K. Fatal haemorrhagic gastritis associated with oral sulindac treatment for patent ductus arteriosus. Acta Paediatr 1996; 85: 884–886
- Papacci P, De Francisci G, Iacobucci T, Giannantonio C, De Carolis MP, Zecca E, Romagnoli C. Use of intravenous ketorolac in the neonate and premature babies. Paediatr Anaesth 2004; 14: 487–492
- Dawkins T N, Barclay C A, Gardiner R L, Krawczeski C D. Safety of intravenous use of ketorolac in infants following cardiothoracic surgery. Cardiol Young 2009; 19: 105–108, Epub 2009 Jan 12
- Zuppa A F, Mondick J T, Davis L, Cohen D. Population pharmacokinetics of ketorolac in neonates and young infants. Am J Ther 2009; 16: 143–146
- Avila-Vazquez M, Maffrand R, Sosa M, Franco M, De Alvarez BV, Cafferata M L, Bergel E. Treatment of retinopathy of prematurity with topical ketorolac tromethamine: a preliminary study. BMC Pediatr 2004; 4: 15